Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Y Chang

Showing results (11-20 of 312) with videos related to

Pageof 32
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 7, 2024
Appreciate the Past, but Embrace the Present and Future: Historical Versus Modern Data of Stereotactic Ablative Radiotherapy for Early-Stage NSCLCJoe Y Chang, Vivek Verma
Translational Lung Cancer Research|February 11, 2021
Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?Vivek Verma, Joe Y Chang
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2022
Optimize Local Therapy for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer to Enhance SurvivalJoe Y Chang, Vivek Verma
Translational Lung Cancer Research|May 18, 2016
Is surgery still the optimal treatment for stage I non-small cell lung cancer?Drew Moghanaki, Joe Y Chang
Journal of Thoracic Disease|August 9, 2016
Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancerUgur Selek, Joe Y Chang
Journal of Thoracic Disease|March 31, 2018
Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancerVivek Verma, Joe Y Chang
Translational Lung Cancer Research|November 6, 2018
Dose-escalation of locally advanced non-small cell lung cancer with proton beam therapyVivek Verma, Joe Y Chang
Pulmonary Medicine|September 12, 2012
Novel insights of oligometastases and oligo-recurrence and review of the literatureYuzuru Niibe, Joe Y Chang
Journal of Thoracic Disease|January 10, 2017
PD-L1 expression in lung cancerChad Tang, Joe Y Chang
Chinese Journal of Cancer|April 30, 2011
Proton therapy in clinical practiceHui Liu, Joe Y Chang
Pageof 32

Showing results (11-20 of 312) with videos related to

Sort By:
Pageof 32
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 7, 2024
Appreciate the Past, but Embrace the Present and Future: Historical Versus Modern Data of Stereotactic Ablative Radiotherapy for Early-Stage NSCLCJoe Y Chang, Vivek Verma
Translational Lung Cancer Research|February 11, 2021
Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?Vivek Verma, Joe Y Chang
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2022
Optimize Local Therapy for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer to Enhance SurvivalJoe Y Chang, Vivek Verma
Translational Lung Cancer Research|May 18, 2016
Is surgery still the optimal treatment for stage I non-small cell lung cancer?Drew Moghanaki, Joe Y Chang
Journal of Thoracic Disease|August 9, 2016
Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancerUgur Selek, Joe Y Chang
Journal of Thoracic Disease|March 31, 2018
Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancerVivek Verma, Joe Y Chang
Translational Lung Cancer Research|November 6, 2018
Dose-escalation of locally advanced non-small cell lung cancer with proton beam therapyVivek Verma, Joe Y Chang
Pulmonary Medicine|September 12, 2012
Novel insights of oligometastases and oligo-recurrence and review of the literatureYuzuru Niibe, Joe Y Chang
Journal of Thoracic Disease|January 10, 2017
PD-L1 expression in lung cancerChad Tang, Joe Y Chang
Chinese Journal of Cancer|April 30, 2011
Proton therapy in clinical practiceHui Liu, Joe Y Chang
Pageof 32